| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70503
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70503
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2018-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2021-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-109438576-B |
| titleOfInvention |
Preparation and application of anti-human CD47 monoclonal antibody |
| abstract |
The invention belongs to the field of antibodies, and particularly relates to a preparation method and application of an anti-human CD47 monoclonal antibody. The invention discloses a highly variable region sequence of the monoclonal antibody. The anti-human CD47 monoclonal antibody provided by the invention has good binding activity, can effectively recognize the expression of CD47 on the surface of a tumor cell, and can effectively recognize the recombinant human CD47 extracellular region protein at the protein level. Meanwhile, the epitope identification of the monoclonal antibody is clear, and the monoclonal antibody can be effectively applied to the diagnosis of CD47 target molecules and the preparation and development of anti-human CD47 monoclonal antibody medicines. |
| priorityDate |
2018-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |